COMPLETEDNA

Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response

NCT05291806•Aventure AB

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Blood Glucose Response

Interventions

Reference Product

Wholegrain product Dose A

+2 more

Locations

1

Sweden

Locations (1)

Aventure AB

Lund, Sweden

Key Dates

Start Date

March 17, 2022

Primary Completion Date

June 13, 2022

Completion Date

June 13, 2022

Last Updated

July 5, 2022

Sponsors

Lead Sponsor

Aventure AB

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 5, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions